Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: HER2 BATs with Pembrolizumab
Sponsor: University of Virginia
Collaborators: Merck Sharp & Dohme LLC